RT Journal Article
SR Electronic
T1 From population to neuron: exploring common mediators for metabolic problems and mental illnesses
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.13.20183525
DO 10.1101/2020.09.13.20183525
A1 Takayanagi, Yoichiro
A1 Ishizuka, Koko
A1 Laursen, Thomas M.
A1 Yukitake, Hiroshi
A1 Yang, Kun
A1 Cascella, Nicola G.
A1 Ueda, Shuhei
A1 Sumitomo, Akiko
A1 Narita, Zui
A1 Horiuchi, Yasue
A1 Niwa, Minae
A1 Taguchi, Akiko
A1 White, Morris F.
A1 Eaton, William W.
A1 Mortensen, Preben B.
A1 Sakurai, Takeshi
A1 Sawa, Akira
YR 2020
UL http://medrxiv.org/content/early/2020/09/14/2020.09.13.20183525.abstract
AB Major mental illnesses such as schizophrenia (SZ) and bipolar disorder (BP) frequently accompany metabolic conditions, but their relationship is still unclear, in particular at the mechanistic level. We implemented an approach of “from population to neuron”, combining population-based epidemiological analysis with neurobiological experiments using cell and animal models based on a hypothesis built from the epidemiological study. We characterized high-quality population data, olfactory neuronal cells biopsied from patients with SZ or BP, and healthy subjects, as well as mice genetically modified for insulin signaling. We accessed the Danish Registry and observed (1) a higher incidence of diabetes in people with SZ or BP and (2) higher incidence of major mental illnesses in people with diabetes in the same large cohort. These epidemiological data suggest the existence of common pathophysiological mediators in both diabetes and major mental illnesses. We hypothesized that molecules associated with insulin resistance might be such common mediators, and then validated the hypothesis by using two independent sets of olfactory neuronal cells biopsied from patients and healthy controls. In the first set, we confirmed an enrichment of insulin signaling-associated molecules among the genes that were significantly different between SZ patients and controls in unbiased expression profiling data. In the second set, olfactory neuronal cells from SZ and BP patients who were not pre-diabetic or diabetic showed reduced IRS2 tyrosine phosphorylation upon insulin stimulation, indicative of insulin resistance. These cells also displayed an upregulation of IRS1 protein phosphorylation at serine-312 at baseline (without insulin stimulation), further supporting the concept of insulin resistance in olfactory neuronal cells from SZ patients. Finally, Irs2 knockout mice showed an aberrant response to amphetamine, which is also observed in some patients with major mental illnesses. The bi-directional relationships between major mental illnesses and diabetes suggest that there may be common pathophysiological mediators associated with insulin resistance underlying these mental and physical conditions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAS and KI are supported by the National Institute of Mental Health MH-105660 and Maryland Stem Cell Research Fund. AS is also supported by MH-094268 Silvio O. Conte center, MH-092443, and MH-107730, as well as foundation grants from Stanley, S-R/RUSK, BBRF. TS (Kyoto University, Japan) is supported by Kakenhi from the Ministry of Education, Culture, Sports, Science and Technology in Japan, and was funded in part by the Takeda and Kyoto University Basic and Clinical Research Project for CNS Drugs. TML was supported by an unrestricted grant from the Stanley Medical Research Institute. PBM was supported by grants from the Danish Strategic Research Council, the Faculty of Social Sciences at Aarhus University, the Lundbeck Foundation, the Stanley Medical Research Institute, and a European Research Council advanced grant (GA 2948338). WWE was supported by NIMH grant 1R34MH007760-01.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Danish Data Protection Agency, Statistics Denmark, and the Danish National Board of Health in which informed consent from each subject is not legally required for registry-based studies. This study was also approved by the Johns Hopkins Hospital IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesLead contact: Akira Sawa (asawa1{at}jhmi.edu).